421PEGFR mutation analysis for prospective patient (pt) selection in AURA3 Phase III trial of osimertinib vs platinum-pemetrexed (plt-pem) in pts with EGFR T790M positive advanced non-small cell lung cancer (NSCLC). (22nd November 2017)

Record Type:: Journal Article
Title:: 421PEGFR mutation analysis for prospective patient (pt) selection in AURA3 Phase III trial of osimertinib vs platinum-pemetrexed (plt-pem) in pts with EGFR T790M positive advanced non-small cell lung cancer (NSCLC). (22nd November 2017)
Main Title:: 421PEGFR mutation analysis for prospective patient (pt) selection in AURA3 Phase III trial of osimertinib vs platinum-pemetrexed (plt-pem) in pts with EGFR T790M positive advanced non-small cell lung cancer (NSCLC)
Authors:: Akamatsu, H
Delmonte, A
John, T
Su, W-C
Lee, J-S
Chang, G-C
Huang, X
Jenkins, S
Dearden, S
Wu, Y-L
Abstract:
Is Part Of:: Annals of oncology. Volume 28(2017)Supplement 10
Journal:: Annals of oncology
Issue:: Volume 28(2017)Supplement 10
Issue Display:: Volume 28, Issue 10 (2017)
Year:: 2017
Volume:: 28
Issue:: 10
Issue Sort Value:: 2017-0028-0010-0000
Page Start:
Page End:
Publication Date:: 2017-11-22
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdx671.010 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12151.xml